compound
Ovagen (20mg Vial) Questions Answered
Ovagen is described in the scientific literature as an ultra‑short regulatory peptide; ultra‑short peptides can modulate gene expression and cellular programs, including in epithelial and parenchymal tissues [1] [2] .
Ovagen (20mg Vial)
Week Daily Dose (mcg) Units (per injection) (mL) Weeks 1–2 800 mcg 12 units (0.12 mL) Weeks 3–4 1200 mcg 18 units (0.18 mL) Weeks 5–6 1600 mcg 24 units (0.24 mL) Weeks 7–12 2000 mcg 30 units (0.30 mL) Route & Frequency: Inject once daily subcutaneously .
Ovagen is described in the scientific literature as an ultra‑short regulatory peptide; ultra‑short peptides can modulate gene expression and cellular programs, including in epithelial and parenchymal tissues [1] [2] .
Week Daily Dose (mcg) Units (per injection) (mL) Weeks 1–2 800 mcg 12 units (0.12 mL) Weeks 3–4 1200 mcg 18 units (0.18 mL) Weeks 5–6 1600 mcg 24 units (0.24 mL) Weeks 7–12 2000 mcg 30 units (0.30 mL) Route & Frequency: Inject once daily subcutaneously .
Plan based on an 8–16 week once‑daily protocol with gradual titration. Peptide Vials (Ovagen, 20 mg each): 8 weeks ≈ 4 vials 12 weeks ≈ 7 vials 16 weeks ≈ 10 vials Insulin Syringes (U‑100): Per week: 7 syringes (1/day) 8 weeks: 56 syringes 12 weeks: 84 syri...
Practical considerations for consistency and safety. Use new sterile insulin syringes; dispose in a sharps container.